comparemela.com

Latest Breaking News On - யேல் குழந்தை ப்ரைமரீ பராமரிப்பு மையம் - Page 1 : comparemela.com

citybizlist : New York : ApiJect Systems, Corp , Announces Company s New Leadership Advisory Board

1/28/21 Heidi J. Larson, Ph.D., ApiJect Systems, Corp, a public benefit corporation based in Stamford, CT., announced today the creation of its new Leadership Advisory Board, along with the appointment of the Board s initial six outside members. They will join ApiJect s co-founder and Chairman, Jay Walker, and company CEO, Franco Negron, on this new Board. Mr. Walker and Mr. Negron will serve as ex-officio board members. ApiJect Systems, Corp., is a global injectable technology company. The company is building the world s largest pharmaceutical fill and finish manufacturing facilities in Durham, North Carolina s Research Triangle Park. The ApiJect campus is projected to produce up to 3 billion doses annually of injectable medicines. ApiJect has also built, using a $138 million grant from the U.S. Department of Defense and the Department of Health and Human Services, an emergency manufacturing capacity in Columbia, South Carolina to produce monthly up to 45 million single-dose pref

ApiJect Systems, Corp , Announces Company s New Leadership Advisory Board

Share this article Share this article STAMFORD, Conn., Jan. 28, 2021 /PRNewswire/ ApiJect Systems, Corp, a public benefit corporation based in Stamford, CT., announced today the creation of its new Leadership Advisory Board, along with the appointment of the Board s initial six outside members. They will join ApiJect s co-founder and Chairman, Jay Walker, and company CEO, Franco Negron, on this new Board. Mr. Walker and Mr. Negron will serve as ex-officio board members. ApiJect Systems, Corp., is a global injectable technology company. The company is building the world s largest pharmaceutical fill and finish manufacturing facilities in Durham, North Carolina s Research Triangle Park. The ApiJect campus is projected to produce up to 3 billion doses annually of injectable medicines. ApiJect has also built, using a $138 million grant from the U.S. Department of Defense and the Department of Health and Human Services, an emergency manufactur

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.